Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Tuesday that Arbli (losartan potassium) Oral Suspension, 10 mg/mL, has ...
PISCATAWAY, N.J., Feb. 28, 2019 /PRNewswire/ -- Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots ...
Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...
Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned ...
The metabolic syndrome represents a specific cluster of phenotypes that increase the risk for coronary heart disease and type-2 diabetes mellitus. 1, 2, 3, 4 Owing to ...
Original Advisory (May 30, 2021): Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity Health Canada is informing Canadians that several companies are recalling ...
Macleods Pharmaceuticals is recalling 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide (HCTZ) combination tablets after discovering trace amounts of the potential ...
Original Advisory (May 30, 2021): Multiple lots of irbesartan, losartan and valsartan drugs recalled due to azido impurity Health Canada is informing Canadians that several companies are recalling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback